{"id":"W3031324523","doi":"10.1016/s2665-9913(20)30066-7","title":"5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University","funders":"Novartis Pharmaceuticals UK Limited; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Secukinumab; Ankylosing spondylitis; Medicine; Measure (data warehouse); Clinical trial; Phase (matter); Internal medicine; Rheumatoid arthritis; Computer science; Data mining; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003205764,0.001966914,0.003192771,0.0002957456,0.0004559589,0.001536313,0.0007437791,0.001675449,0.002136744],"category_scores_gemma":[0.002430387,0.0004283577,0.00448006,0.0003133146,0.0007751084,0.001540116,0.0005348448,0.003136155,0.0004897731],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006903707,"about_ca_system_score_gemma":0.0005853184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005347846,"about_ca_topic_score_gemma":0.001251459,"domain_scores_codex":[0.9987697,0.000652409,0.00008220097,0.0001544584,0.0001224722,0.0002187459],"domain_scores_gemma":[0.9981683,0.0006092248,0.0005662196,0.0001689131,0.000118858,0.0003683663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9433178,0.002622347,0.01473154,0.0009093503,0.008702815,0.000134962,0.0001167282,0.00125067,0.002179404,0.0001793705,0.001577207,0.0242779],"study_design_scores_gemma":[0.6809694,0.1658673,0.1307575,0.0003270594,0.01339634,0.0004405514,0.0002092358,0.001983765,0.001802746,0.0009731916,0.00314582,0.0001270723],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858849,0.01052092,0.0002405543,0.0004538466,0.000193176,0.0001872728,0.001170442,0.00004788542,0.001300961],"genre_scores_gemma":[0.9945542,0.00165142,0.000238228,0.0005902039,0.0002307897,0.0002374505,0.001712746,0.00001343758,0.0007715201],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003205764,"threshold_uncertainty_score":0.01695389,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03062192535098186,"score_gpt":0.2818879644821985,"score_spread":0.2512660391312166,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}